Previous Article | Next Article ![]()
Infection and Immunity, November 2000, p. 6457-6460, Vol. 68, No. 11
MedImmune, Inc., Gaithersburg, Maryland 20878
Received 14 April 2000/Returned for modification 12 June
2000/Accepted 24 August 2000
Mice immunized with either the predominantly vector-stage
lipoprotein outer surface protein A (OspA) or the in vivo-expressed lipoprotein decorin binding protein A (DbpA) are protected against Borrelia burgdorferi challenge. DbpA-OspA combinations
protected against 100-fold-higher challenge doses than did either
single-antigen vaccine and conferred significant protection against
heterologous B. burgdorferi, B. garinii, and
B. afzelii isolates, suggesting that there is synergy
between these two immunogens.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evidence for Vaccine Synergy between Borrelia
burgdorferi Decorin Binding Protein A and Outer Surface Protein A
in the Mouse Model of Lyme Borreliosis
*
Corresponding author. Mailing address: MedImmune, Inc.,
35 W. Watkins Mill Rd., Gaithersburg, MD 20878. Phone: (301) 527-4264. Fax: (301) 527-4200. E-mail: hansonm{at}medimmune.com.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|